Victory in the Aloha State

After more than a decade of advocacy by Hawaiian patient and provider advocacy organizations, Hawaii Governor Josh Green signed HB 1864 into law on July 9, 2026. This legislation requires state-regulated health insurers to cover standard fertility preservation services for individuals facing iatrogenic infertility, including cancer patients. The new law will cover procedures such as sperm banking and egg and embryo freezing and go into effect for health plans issued or renewed in Hawaii after December 31, 2026.

Due to Hawaii’s Prepaid Health Care Act of 1974 (PHCA) – the nation’s only state employer health coverage mandate that predates federal ERISA law – coverage will reach a broader percentage of Hawaii’s population compared to other state fertility preservation laws. We estimate that more than 700,000 Hawaiians, approximately half of the state’s population, will now have fertility preservation coverage should they ever need it.

The Alliance for Fertility Preservation would like to thank every patient advocate and organization that has been fighting tirelessly for this coverage since the first Hawaii bill was introduced in 2012. We are especially grateful for the Hawaii Society of Clinical Oncology, ASCO, Fertility Institute of Hawaii, Breast Cancer Hawaii, ACS CAN, Blood Cancer United, Susan G. Komen and all of the patient advocates who bravely shared their stories throughout this long journey.

Fertility Preservation Toolkit

Thank you for your interest in our toolkits. Please read our Terms of Use carefully as we include information that applies to all our toolkits.

All toolkits are publicly available for individual use without licensing or royalty fees. Such use of toolkits is “single use,” meaning solely for the User’s research, clinical, educational, or other application. User’s email may be added to an email distribution list to receive scientific and updated information about the toolkit(s).

We encourage use of our toolkits. User agrees not to adapt, alter, amend, abridge, modify, condense, make derivative works, or translate toolkits without prior written permission from the Provider. User agrees not to sell or incorporate toolkits into materials that could be sold without prior written consent from the Provider. To inquire about permissions, please email info@a4fp.org.


Infertility and Advancing Therapeutic Solutions for IVF

Externally-Led Patient-Focused Drug Development
(EL-PFDD) Meeting

March 26, 2026

Sessions

Session 1 – Living with Infertility or Fertility Loss: Impacts on Daily Life
  • When did you become aware of your infertility or potential for fertility loss?
  • What has had the biggest impact on your life (physical, emotional, and/or psychosocial)?
  • Does infertility or concerns about your future fertility affect daily life? Has this changed over time?
  • Are there activities, goals, or life plans that have been altered as a result?
  • When you think about the future, what worries or uncertainties concern you most?
Session 2 – Current & Future Approaches to Preserve or Restore Fertility
  • What treatments have you/your loved one used to try to preserve fertility or to build a family? How well did these work?
  • What are/were the most significant downsides (physical and/or emotional) side effects?
  • How did you weigh the pros/cons of fertility treatment?
  • Would you participate in clinical trials for fertility-protective or restorative therapies?
  • What improvements or types of therapies would you like to see in the future?

Thank You

We are able to organize this event and bring patients together from across the country to share their experiences thanks to the generous support of our corporate sponsor, EMD Serono, and through a partnership with the Cade Foundation.